IP Library Patent Application 11346560
Patent Application
App. No. 11/346,560

Devices for delivering agents to a vaginal tract

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/346,560
Abstract

The present invention is directed to devices for delivering agents to a vaginal tract, a device of the invention comprises a non-porous polymeric material substantially impermeable to an environment of the vaginal tract, the non-porous polymeric material forming a closed envelope which forms an internal space, wherein the closed envelope contains two or more distinct apertures.

Claims (63)

1 . A vaginal device comprising a non-porous polymeric material substantially impermeable to an environment of the vaginal tract, the non-porous polymeric material forming a closed envelope which forms an internal space, wherein the closed envelope contains two or more distinct apertures.

2 . The device of claim 1 , wherein the closed envelope forms greater than one internal space.

3 . The device of claim 1 , wherein the closed envelope forms from one to six internal spaces.

4 . (canceled)

5 . The device of claim 1 , further comprising a matrix contained within the internal space.

6 . (canceled)

7 . The device of claim 5 , wherein the matrix further comprises an agent capable of diffusing from the matrix into the vaginal tract.

8 . (canceled)

9 . (canceled)

10 . (canceled)

11 . The device of claim 7 , wherein the agent is released from the device to the environment of the vaginal tract at a rate of about 0.001 mg/day to about 100 mg/day.

12 . (canceled)

13 . (canceled)

14 . The device of claim 7 , wherein the distinct apertures contain a second agent different from the agent in the matrix.

15 . The device of claim 14 , wherein the second agent prevents clogging of the distinct apertures.

16 . (canceled)

17 . (canceled)

18 . (canceled)

19 . The device of claim 7 , wherein the non-porous polymeric material comprises a second agent different from the agent in the matrix.

20 . The device of claim 19 , wherein the second agent is an agent that prevents clogging of the distinct apertures.

21 . (canceled)

22 . (canceled)

23 . (canceled)

24 . A method of administering an agent to a subject in need of the agent, the method comprising administering the device of claim 7 to the subject.

25 . The method of claim 24 , wherein the administering of an agent occurs continuously for about one hour to about one year.

26 . (canceled)

27 . (canceled)

28 . The device of claim 1 , wherein at least one of the distinct apertures has a length and a width having a ratio of less than 20:1.

29 . The device of claim 1 , wherein the closed envelope has a thickness of between about 5 μm to about 1 cm.

30 . (canceled)

31 . (canceled)

32 . The device of claim 1 , wherein the non-porous polymeric material is a thermoplastic material, thermoplastic elastomeric material, thermosetting material or combinations thereof.

33 . (canceled)

34 . The device of claim 32 , wherein the thermoplastic material is a thermoplastic olefin blend, a crosslinked polymer, a copolymer, a block copolymer, or combinations thereof.

35 . (canceled)

36 . (canceled)

37 . (canceled)

38 . (canceled)

39 . (canceled)

40 . (canceled)

41 . (canceled)

42 . (canceled)

43 . The device of claim 1 , wherein the closed envelope is annular in shape.

44 . The device of claim 43 , wherein the closed envelope is an intravaginal ring.

45 . The device of claim 1 , wherein the distinct apertures are formed by laser drilling.

46 . (canceled)

47 . (canceled)

48 . (canceled)

49 . (canceled)

50 . (canceled)

51 . (canceled)

52 . (canceled)

53 . (canceled)

54 . A method of making a device for delivering an agent to a vaginal tract, the method comprising:

(a) forming a closed envelope comprising a non-porous polymeric material substantially impermeable to an environment of the vaginal tract, wherein the closed envelope forms an internal space; and

(b) forming two or more distinct apertures in the closed envelope of (a).

55 . The method of claim 54 further comprising:

(c) placing a matrix containing an agent into the internal space of (a), thus forming a matrix encased by the closed envelope.

56 . The method of claim 55 wherein the distinct apertures are formed by laser drilling.

57 . A method of making a device for delivering an agent to a vaginal tract, the method comprising:

(a) forming a closed envelope comprising a non-porous polymeric material substantially impermeable to an environment of the vaginal tract, wherein the closed envelope forms an internal space;

(b) forming two or more distinct apertures in the closed envelope of (a); and

(c) placing a matrix containing an agent into the internal space of (a), thus forming a matrix encased by the closed envelope.

Assignments (2)
CHANGE OF NAME Recorded May 19, 2010
From: DURAMED PHARMACEUTICALS, INC.
To: TEVA WOMEN'S HEALTH, INC.
Reel/Frame 024402/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2006
From: BRONNENKANT, LANCE J.; MAHASHABDE, ANU
To: DURAMED PHARMACEUTICALS, INC.
Reel/Frame 017799/0756 →